True Wealth Design’s Pacira BioSciences PCRX Stock Holding History

True Wealth Design’s Portfolio PCRX Stock Details PCRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$8.54K	Hold	341	–	–	﹤0.01%	1137
2026 Q2	$8.65K	Hold	341	–	–	﹤0.01%	1115
2026 Q1	$7.71K	Hold	341	–	–	﹤0.01%	1062
2025 Q4	$8.83K	Hold	341	–	–	﹤0.01%	910
2025 Q3	$8.79K	Hold	341	–	–	﹤0.01%	883
2025 Q2	$8.15K	Hold	341	–	–	﹤0.01%	647
2025 Q1	$8.47K	Hold	341	–	–	﹤0.01%	521
2024 Q4	$6.42K	Buy	341 +78	+30%	+$1.37K	﹤0.01%	491
2024 Q3	$3.96K	Buy	+263	New	+$4.5K	﹤0.01%	617

Other funds holding PCRX

HWAM

Hennion & Walsh Asset Management Parsippany, New Jersey $3.42B AUM 25.82% 1-Year Est. Return

Wedge Capital Management Charlotte, North Carolina $5.72B AUM 38.26% 1-Year Est. Return

Ellsworth Advisors Hudson, Ohio $620M AUM 38.17% 1-Year Est. Return

State of Alaska Department of Revenue Juneau, Alaska $9.6B AUM 34.67% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return

VCM

Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return

ATC

Adirondack Trust Company Saratoga Springs, New York $320M AUM 23.25% 1-Year Est. Return

Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

True Wealth Design's PCRX Position: Q3 2026 in Review

True Wealth Design held its Pacira BioSciences (PCRX) position steady in Q3 2026 at 341 shares worth $8.54K. The position accounts for ﹤0.01% of the portfolio, ranked #1137.

True Wealth Design first reported a position in PCRX in Q3 2024 and has held it in 9 quarters since. The position peaked at $8.83K in Q4 2025. 17 funds tracked by Wall St. Rank hold PCRX as of Q3 2026.

True Wealth Design held 341 shares of Pacira BioSciences worth $8.54K as of Q3 2026.
True Wealth Design left its Pacira BioSciences share count unchanged in Q3 2026.
Pacira BioSciences made up ﹤0.01% of True Wealth Design's portfolio in Q3 2026, its #1137 holding.
True Wealth Design first reported a position in Pacira BioSciences in Q3 2024 and has held it in 9 quarters since.
True Wealth Design's Pacira BioSciences position peaked at $8.83K in Q4 2025.
17 funds tracked by Wall St. Rank held Pacira BioSciences as of Q3 2026.

Based on True Wealth Design's 13F filing for Q3 2026, filed 13 Oct 2026.